Combined Strategies with Poly (ADP-Ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer: A Literature Review.

Diagnostics (Basel) · 2019 · PMC6787707 · PMID 31374917

Europe PMC DOI

hedged sentence

0.2200

closest p · 4.4× alpha

0.2200

boldest claim

The sentences

a slight trendp = 0.22not close (p > 0.1)

BRCA status from tumour exome analysis exhibited a slight trend toward an effect in patients treated with the combination ( p = 0.22), indicating a role in the prognosis.

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.